Jiangsu Hengrui Pharma A/H Trading - Strong Demand for Quality Asset, but Is Pricey
Jiangsu Hengrui Pharmaceuticals (1276 HK) (JHP, 600276 CH ), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing....
418 Views
[Blue Lotus Daily]:LI US/1211 HK/XPEV US/1810 HK/Macro
NEV sales rankings for May 12-18, 2025 released; Denza and Formula Leopard units merged back into parent company; Xuanjie O1 chip enters mass...
189 Views
Xiamen Hithium Pre-IPO: Potential Data Center Play
Xiamen Hithium (XH) is looking to raise at least US$500m in its upcoming HK IPO. It is a potential data-center growth play. In this note, we look...
415 Views
Chery IPO Preview: More Than A Local Hero, Chery’s Road To IPO Glory
Chery Auto, China's #2 domestic passenger vehicle brand, aims to raise over $1B in Hong Kong IPO, driven by strong overseas presence and focus on...
583 Views
Eastroc Beverage A/H Listing - Energized - Fast Growth, Better Margins
Eastroc Beverage Group (605499 CH) (EB), a China-based functional beverage company, aims to raise around US$1bn in its H-share listing. In this...
481 Views